BETA

A3P Biomedical

Biocrine

byWiT

Cascade Drives

Dirac Research

Doktor.se

Exeger

GreenGold Group

Kaunis Iron

Klarna

Marshall Group

MEDS Pharmacy

Mentimeter

Nicoya

Virtune

Xshore

Yabie

Biocrine Stock

HealthcareBiotechnologyPharmaceuticals
Biocrine conducts research at Karolinska Institutet in the field of diabetes. The research is an initiative with the aim of commercializing new diabetes treatments and enabling the delivery of drugs for diabetes and related complications. 

Public company

28/02/2025

Bid

Ask

Latest trade

Marknadsvärde

Right of first refusal! For info contact us
All time Chevron
  • 3 months
  • 6 months
  • 12 months
  • YTD
  • Previous year
  • All time

6 months

SEK

Primary
Secondary

Price is based on the latest closing on the date indicated

Biocrine

Biocrine conducts research at Karolinska Institutet in the field of diabetes. The research is an initiative with the aim of commercializing new diabetes treatments and enabling the delivery of drugs for diabetes and related complications. 

Buy BioCrine shares

  • Selling and buying shares in Biocrine AB is possible through our convenient platform for unlisted shares. 
  • Please contact us if you have any questions or concerns regarding shares in BioCrine AB, create an account if you want to place an order in the company.

Biocrine is connected to Euroclear, after execution of the order, the shares are delivered to your custody account at any bank or securities company.

About the share

Info from the financial statements 2023
Name

BioCrine AB

Org. Number

556727-7933

Result after net financial items

SEK -9 803 THOUSAND

Turnover

1 290 TSEK

Number of shares

296 885 st

Profit before tax

SEK -9 803 THOUSAND

Dividends

Current liabilities

3 629 TSEK

Long-term liabilities

-

Dividend per share

-

10 Largest Shareholders BioCrine AB

Info from Euroclear

Name

capital

Name

capital

  • Lars Spanberg

    10,41%

  • Per-Olof Berggren

    10,1%

  • Svipdag AB

    5,52%

  • Kenth Persson

    4,55%

  • UBP CLIENTS ASSETS - SWEDEN

    4,42%

  • THOMAS ANDERSSON BORSTAM

    4,38%

  • MENSURA EFENDIC

    4,18%

  • LIMITED LIABILITY COMPANY THE MINISTER

    3,47%

  • Per Staffan Rasjo

    3,37%

  • Nordnet Pensionsförsäkring AB

    3,21%

Last updated on 27-03-2025

About the pipeline

Info from the financial statements 2023
CEO

Yngve Per-Olof Berggren

The President

Kenth Ingemar Petersson

Financial reports and press releases

About BioCrine

Biocrine is a Swedish biotechnology company focused on research and development in the field of diabetes and hormonal health. The company was founded in 2007 and has its headquarters in Stockholm. Biocrine works closely with leading research institutions and experts to drive innovative solutions in its field.

Research and technology

Biocrine is particularly focused on understanding the molecular mechanisms of hormone release and its role in diabetes and its complications. The company works closely with the Rolf Luft Research Center for Diabetes and Endocrinology at the Karolinska Institute, one of the world's leading research institutions in this field. Leading scientists such as Per-Olof Berggren and Suad Efendic have played a central role in developing Biocrine's research strategies.

Business model

Biocrine aims to commercialize breakthrough treatments and technologies for diabetes and related diseases. The company is engaged in both research and development and marketing of innovative biotechnology solutions. Through collaboration with both academic institutions and industry, Biocrine creates new opportunities for patients and healthcare.

Funding and future

Biocrine continues to work on developing and commercializing its technologies in research and innovation. The company has carried out several rights issues since 2023, the latest of which raised SEK 8.2 million at a valuation of SEK 326.6 million. Previously, another rights issue in 2023 generated 14 MSEK at a valuation of 284.9 MSEK.

How to buy shares in Biocrine

  1. Create an account on Eqvor.com
  2. Click on the buy button next to Biocrine in the OTC list.
  3. Choose how many shares you want to buy and at what price, and to which depository you want the shares delivered.
  4. Wait for the order to be matched.
  5. Send your settlement note to your bank/securities company.
  6. The shares land in your custody - Done!

 

In addition to Biocrine, we have also helped investors buy and sell shares in other exciting unlisted companies in sectors such as 

Hbiotechnology and bioengineering, there are A3P Biomedical, Doktor.se, MEDS Pharmacy, Sigrid Therapeutics and Mindler. Under financial services there are Klarna, Mynt, Yabie and Billogram.

Within technology and innovation: Dirac Research, Exeger, Cascade Drives, Sana Labs, Quartr and Virtune. I the consumer and lifestyle segment: CDLP, Estrid and Marshall.

Under transport and vehicle technology there are Einride, Voi, XShore, Koenigsegg and Candela. Within energy and sustainability: Blykalla and Svea Solar.

In addition: Epidemic Sound (media), Kaunis Iron (industry),  GreenGold Group (forestry), and investment companies Röko, byWiT and Nicoya.

We can also help to implement deals in other unlisted companies - even if they are not listed on the platform. Contact us if you are looking for a specific case.

Frequently asked questions and answers about Biocrine

01

Is Biocrine listed on the stock exchange?

No, Biocrine is not listed on the stock exchange. If you want to buy shares before listing, you can do so on Eqvor.com

02

Is Biocrine connected to Euroclear?

Yes, Biocrine is connected to Euroclear, which means you can keep your shares in a regular share depository.

03

At what price is Biocrine traded?

Log in to Eqvor.com to access the latest Biocrine courses.

04

When will Biocrine be listed on the stock exchange?

There is currently no explicit plan to go public.

05

Can I store Biocrine shares on Avanza?

Yes, you can keep the shares in a regular share depository at Avanza.

06

What is Biocrine's valuation?

To see the valuation of Biocrine create an account on Eqvor and you will see the current valuation at the top of this page under the heading "Market capitalization" this valuation is calculated based on the last trade in the stock.

07

When did Biocrine last issue shares?

To see the latest issue in Biocrine log in to Eqvor and look at the graph, where you will see a purple dot in the graph for each issue with the capital raised and the share price at each issue.

For more information or questions, please contact us

Login

Don't have an account? Create account

Create account

Already have an account? Login

Hur hittade du Eqvor? (valfritt)

When you create an account, you certify that you have read all the information and documents we publish here

Want to be notified by email when stock prices are updated for the companies we have listed?

Monitor stock prices